The Gross Margin of Neuren Pharmaceuticals Ltd (NEU.AX) is 18.56%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 18.56% |
| 2023-12-31 | 12.65% |